FEMOGEN Drug Patent Profile
✉ Email this page to a colleague
When do Femogen patents expire, and when can generic versions of Femogen launch?
Femogen is a drug marketed by Pvt Form and is included in three NDAs.
The generic ingredient in FEMOGEN is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FEMOGEN?
- What are the global sales for FEMOGEN?
- What is Average Wholesale Price for FEMOGEN?
Summary for FEMOGEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 108 |
Patent Applications: | 4,127 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FEMOGEN at DailyMed |
US Patents and Regulatory Information for FEMOGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pvt Form | FEMOGEN | estrogens, esterified | TABLET;ORAL | 085076-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pvt Form | FEMOGEN | estrogens, esterified | TABLET;ORAL | 085008-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pvt Form | FEMOGEN | estrogens, esterified | TABLET;ORAL | 085007-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |